Dreman Value Management’s Gilead Sciences GILD Stock Holding History

Dreman Value Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	$1.05M	Sell	13,871 -956	-6%	-$76K	0.47%	49
2017 Q4	$1.06M	Buy	14,827 +3,895	+36%	+$296K	0.6%	51
2017 Q3	$886K	Sell	10,932 -1,213	-10%	-$92.8K	0.49%	70
2017 Q2	$860K	Sell	12,145 -8,029	-40%	-$534K	0.47%	73
2017 Q1	$1.37M	Sell	20,174 -550	-3%	-$38.7K	0.78%	30
2016 Q4	$1.48M	Sell	20,724 -1,131	-5%	-$84.1K	0.83%	24
2016 Q3	$1.73M	Sell	21,855 -691	-3%	-$56.1K	1.05%	30
2016 Q2	$1.88M	Sell	22,546 -664	-3%	-$58.9K	1.16%	23
2016 Q1	$2.13M	Buy	+23,210	New	+$2.09M	0.24%	117
2015 Q4	–	Sell	-11,228	Closed	-$1.1M	–	273
2015 Q3	$1.1M	Buy	11,228 +1,703	+18%	+$189K	0.11%	171
2015 Q2	$1.11M	Buy	9,525 +3,945	+71%	+$431K	0.09%	208
2015 Q1	$548K	Buy	+5,580	New	+$567K	0.05%	245
2014 Q4	–	Sell	-2,388	Closed	-$254K	–	486
2014 Q3	$254K	Buy	+2,388	New	+$234K	0.02%	270

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Dreman Value Management's GILD Position: Q1 2018 in Review

Dreman Value Management reduced its Gilead Sciences (GILD) stake by 6.4% in Q1 2018, selling an estimated $76K and leaving 13,871 shares worth $1.05M. The position accounts for 0.47% of the portfolio, ranked #49.

Dreman Value Management first reported a position in GILD in Q3 2014 and has held it in 13 quarters since. The position peaked at $2.13M in Q1 2016. 1,563 funds tracked by Wall St. Rank hold GILD as of Q1 2018.

Dreman Value Management held 13,871 shares of Gilead Sciences worth $1.05M as of Q1 2018.
Dreman Value Management sold 956 Gilead Sciences shares in Q1 2018, an estimated $76K.
Gilead Sciences made up 0.47% of Dreman Value Management's portfolio in Q1 2018, its #49 holding.
Dreman Value Management first reported a position in Gilead Sciences in Q3 2014 and has held it in 13 quarters since.
Dreman Value Management's Gilead Sciences position peaked at $2.13M in Q1 2016.
1,563 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2018.

Based on Dreman Value Management's 13F filing for Q1 2018, filed 2 May 2018.